| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/29/2006 | WO2006066949A1 Compositions comprising an epothilone and production methods |
| 06/29/2006 | WO2006066948A1 Piperidine derivatives as antagonists of the cc chemokine receptor ccr1 and their use as anti-inflammatory agents |
| 06/29/2006 | WO2006066941A2 Natural extract containing xanthohumol, and method for the production thereof and products produced therefrom |
| 06/29/2006 | WO2006066932A1 Stable pharmaceutical composition comprising an active substance in the form of solid solution |
| 06/29/2006 | WO2006066930A1 Stable pharmaceutical composition comprising amoxicillin and clavulanic acid |
| 06/29/2006 | WO2006066929A1 Quaternary ammonium salts as m3 antagonists |
| 06/29/2006 | WO2006066928A1 Pyrrolinidium derivatives as m3 muscarinic receptors |
| 06/29/2006 | WO2006066924A2 Azole derivatives with antimuscarinic activity |
| 06/29/2006 | WO2006066923A2 Indole derivatives with antitumor activity |
| 06/29/2006 | WO2006066907A1 Pharmaceutical formulations |
| 06/29/2006 | WO2006066899A1 Novel thrombin inhibitors |
| 06/29/2006 | WO2006066896A2 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 06/29/2006 | WO2006066894A1 Compounds for treating metabolic syndrome |
| 06/29/2006 | WO2006066885A1 Substituted n-heterocyclic compounds and their use as dopamine d3 receptor ligands |
| 06/29/2006 | WO2006066879A2 Compounds with kv4 ion channel activity |
| 06/29/2006 | WO2006066847A1 Activator for insulin degrading enzyme |
| 06/29/2006 | WO2006066846A1 Use of thiazolidinone derivatives as antiangiogenic agents |
| 06/29/2006 | WO2006066795A1 2,5- and 2,6-disubstituted benzazole derivatives useful as protein kinase inhibitors |
| 06/29/2006 | WO2006066788A1 Transdermal plaster with progesterone a-specific ligands (prasl) as an active ingredient |
| 06/29/2006 | WO2006066780A1 Combinations of valategrast and montelukast for treating asthma |
| 06/29/2006 | WO2006066779A1 Novel cyclohexane derivatives |
| 06/29/2006 | WO2006066775A1 Use of diketodithiopiperazine antibiotics for the preparation of antiangiogenic pharmaceutical compositions |
| 06/29/2006 | WO2006066770A1 Cycloalkylamine derivatives |
| 06/29/2006 | WO2006066756A1 Chroman derivatives and uses thereof in the treatment of cns disorders |
| 06/29/2006 | WO2006066748A1 Tetralin and indane derivatives and uses thereof as 5-ht antagonists |
| 06/29/2006 | WO2006066747A1 4-aminopiperidine derivatives |
| 06/29/2006 | WO2006066746A1 Chroman derivatives and their use as 5-ht receptor ligands |
| 06/29/2006 | WO2006066745A1 Tetralin and indane derivatives and uses thereof |
| 06/29/2006 | WO2006066694A1 Method for the production of oxazoles by condensing aromatic aldehydes with a-ketoximes to n-oxides and then reacting the same with activated acid derivatives |
| 06/29/2006 | WO2006066693A1 Novel cyclic ureas used as inhibitors of metalloproteases |
| 06/29/2006 | WO2006066645A2 Use of a container made of a plastic material containing an inorganic additive |
| 06/29/2006 | WO2006066643A1 Esters of choline and fatty acids with bactericide activity and products containing such esters for cosmetic or dermo-pharmaceutical products |
| 06/29/2006 | WO2006066637A1 Use of cyclodextrin complexes containing lipoic acid |
| 06/29/2006 | WO2006066584A1 Novel cyanoguanidine compounds |
| 06/29/2006 | WO2006066512A1 Pyrimidinone compounds, their preparation and use thereof |
| 06/29/2006 | WO2006066511A1 Diazene-bridged crown ether lithium compounds and methods for their use |
| 06/29/2006 | WO2006066509A1 Injectable sustained release microspheric preparation of 3,3-diphenylpropylamine derivatives as muscarinic receptor antagonists |
| 06/29/2006 | WO2006066419A1 Mixture of a vanilloid receptor agonist and a substance inhibiting nerve regeneration, use thereof for producing a painkiller, and method for applying said painkiller |
| 06/29/2006 | WO2006066414A1 Hydroxydihydropyridopy razine-1,8-diones and methods for inhibiting hiv integrase |
| 06/29/2006 | WO2006066408A1 Cancer specific antibody and cell surface proteins |
| 06/29/2006 | WO2006066404A1 Therapeutic nutrient compositions or combinations and methods of their use |
| 06/29/2006 | WO2006066362A1 Methods of treating pain |
| 06/29/2006 | WO2006066361A1 Method of treatment or prophylaxis |
| 06/29/2006 | WO2006066323A1 Formulations and treatments for trichology |
| 06/29/2006 | WO2006060390A1 Quinoline tachykinin receptor antagonists |
| 06/29/2006 | WO2006058029A3 Method of treating opioid dependency |
| 06/29/2006 | WO2006057886A3 2-METHYLENE-19,26,27-TRINOR-(20S)-1α-HYDROXYVITAMIN D3 AND ITS USES |
| 06/29/2006 | WO2006057885A3 17,20(e)-dehydro vitamin d analogs and their uses |
| 06/29/2006 | WO2006055565A3 Control of parasites in animals by the use of parasiticidal 2-phenyl-3-(1h-pyrrol-2-yl) acrylonitrile derivatives |
| 06/29/2006 | WO2006054298A3 Glycogen synthase kinase-3 inhibitors |
| 06/29/2006 | WO2006054278A3 Variants of pigment epithelium derived factor and uses thereof |
| 06/29/2006 | WO2006053791A3 Compounds that modulate ppary type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 06/29/2006 | WO2006053160A3 Methods and compositions using immunomodulatory compounds for treatment and management of parasitic diseases |
| 06/29/2006 | WO2006052889A3 Quinolinone-carboxamide compounds |
| 06/29/2006 | WO2006050315A3 Aliphatic amine polymer salts for tableting |
| 06/29/2006 | WO2006042950A3 Use of pyrrolopyrazine derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells |
| 06/29/2006 | WO2006039721A3 Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases |
| 06/29/2006 | WO2006039667A3 Water-based delivery systems |
| 06/29/2006 | WO2006035157A3 Substituted n-(benzyl)phenylacetamide derivative compounds, preparation method thereof and uses of same as ppar ligands in the treatment of lipid and/or glucidic disorders |
| 06/29/2006 | WO2006033947A3 Use of 2-phenyl-1, 2-ethanediol- (di) carbamates for treating epileptogenesis and epilepsy |
| 06/29/2006 | WO2006030322A3 Use of fla vone/fla vanone derivatives fn the treatment or prevention of respiratory conditions |
| 06/29/2006 | WO2006028269A3 Thiazole derivatives having vap-1 ihibitory activity |
| 06/29/2006 | WO2006026034A3 Processes for the preparation of isothiazole derivatives |
| 06/29/2006 | WO2006024784A3 Aminoglycoside analogues, uses thereof for treating microbial diseases and synthesis thereof |
| 06/29/2006 | WO2006024024A3 Solid and crystalline ibandronate sodium and processes for preparation thereof |
| 06/29/2006 | WO2006021893A3 Pharmaceutical compositions comprising inhibitors of iron transport, and method of identifying iron transport inhibitors, fn staphylococcus aureus |
| 06/29/2006 | WO2006018314A3 Immune stimulatory infant nutrition |
| 06/29/2006 | WO2006017836A3 2-amino-quinazoline derivatives useful as inhibitors of beta-secretase (bace) |
| 06/29/2006 | WO2006017188A3 Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients |
| 06/29/2006 | WO2006016262A8 Combination of a selective noradrenaline reuptake inhibitor and a pdev inhibitor |
| 06/29/2006 | WO2006010153A3 Lipid-amino acid conjugates and methods of use |
| 06/29/2006 | WO2006006082A3 Multi-ring compounds for regulating gut motility, food intake, and weight gain |
| 06/29/2006 | WO2006002375A3 Method of treating ileus by pharmacological activation of cholinergic receptors |
| 06/29/2006 | WO2006000222A3 The combination of an antipsychotic and a glycine transporter type i inhibitor for the treatment of schizophrenia |
| 06/29/2006 | WO2005117848A3 Vascular targets for detecting, imaging and treating neoplasia or neovasculature |
| 06/29/2006 | WO2005115480A3 Modified protein kinase a-specific oligonucleotides and methods of their use |
| 06/29/2006 | WO2005115471A8 Methods and compositions for treatment of nicotine dependence and dementias |
| 06/29/2006 | WO2005115396A3 Combination of atomoxetine and a 5t1a receptor agonist for treating adhd and other disorders |
| 06/29/2006 | WO2005110277A3 Carboxylated polysaccharides and method of preparation and use |
| 06/29/2006 | WO2005107730A3 Cysteamines for treating complications of hypercholesterolemia and diabetes |
| 06/29/2006 | WO2005105049A3 Orally disintegrating tablets and methods of manufacture |
| 06/29/2006 | WO2005094457B1 Novel anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (ryr2) and uses thereof |
| 06/29/2006 | WO2005082414A3 Concomitant drugs of a sulfonamide and another therapeutic agent |
| 06/29/2006 | WO2005072246A3 Facially amphiphilic polyaryl and polyarylalkynyl polymers and oligomers and uses thereof |
| 06/29/2006 | WO2005051290A8 Methods and formulations for the treatment of medical conditions related to elevated dihydrotestosterone |
| 06/29/2006 | WO2005041881A8 Taxoid-fatty acid conjugates and pharmaceutical compositions thereof |
| 06/29/2006 | WO2005010164A3 Nucleic acid biomaterials and methods of formation and use |
| 06/29/2006 | WO2005001092A3 Compositions and methods for diagnosing and treating cancers |
| 06/29/2006 | WO2004093885A9 Compositions containing lactulose for treating potavirus infections |
| 06/29/2006 | WO2004066935A3 Sensitive proteasome sensor constructs and methods for their design and use |
| 06/29/2006 | WO2004002412A3 A method and composition to elicit an effective autologous antitumoral immune response in a patient |
| 06/29/2006 | US20060142685 Directly injected to fill irregular contours; healing and exudate management; reacts with such as castor oil; kits |
| 06/29/2006 | US20060142624 Prepared by contacting aromatic hydrocarbon with olefin under alkylation conditions in presence of catalyst having macropore structure comprising zeolite Y; preparation of carbonated, overbased aromatic sulfonates by alkylation, carbonation of aromatic hydrocarbons with one or more olefins |
| 06/29/2006 | US20060142594 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 06/29/2006 | US20060142592 atorvastatin calcium epoxide dihydroxy (AED) is described; AED can be used as a standard or marker in determining the amount of AED in a sample |
| 06/29/2006 | US20060142586 Synthesis of 2-alkyl amino acids |
| 06/29/2006 | US20060142582 Crystalline forms of pitavastatin calcium |
| 06/29/2006 | US20060142580 N-phenyl-2-pyrimidine-amine derivatives |
| 06/29/2006 | US20060142579 crystallizing from a solvent selected from 1-propanol, 2-propanol, 1-butanol, ethyl acetate, acetonitrile |
| 06/29/2006 | US20060142577 4-Diethylamino-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-3-(trifluoromethyl)-benzamide; disease which responds to an inhibition of protein kinase activity, especially a neoplastic disease; leukemia |